Close Menu

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – PathoGenetix, formerly called US Genomics, announced today the first closing of its Series B financing round, raising $4 million.

The Woburn, Mass.-based company added that it has received $9.5 million in commitments from investors for the round.

The funds will be used to complete development of PathoGenetix's first commercial systems for identifying pathogens in complex biological samples using its Genome Sequence Scanning technology.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more. 

Feb
05
Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
20
Sponsored by
Thermo Fisher Scientific

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.